Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus

OBJECTIVE: To evaluate the frequency of cell‐bound complement activation products (CB‐CAPs) as a marker of complement activation in patients with suspected systemic lupus erythematosus (SLE) and the usefulness of this biomarker as a predictor of the evolution of probable SLE into SLE as classified b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsey‐Goldman, Rosalind, Alexander, Roberta Vezza, Massarotti, Elena M., Wallace, Daniel J., Narain, Sonali, Arriens, Cristina, Collins, Christopher E., Saxena, Amit, Putterman, Chaim, Kalunian, Kenneth C., O'Malley, Tyler, Dervieux, Thierry, Weinstein, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972605/
https://www.ncbi.nlm.nih.gov/pubmed/31469249
http://dx.doi.org/10.1002/art.41093

Ejemplares similares

Ejemplares similares